Cepheid Company Profile (NASDAQ:CPHD)

About Cepheid

Cepheid logoCepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Scientific & Technical Instruments
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: CPHD
  • CUSIP: 15670R10
Key Metrics:
  • Previous Close: $52.69
  • 50 Day Moving Average: $43.67
  • 200 Day Moving Average: $34.47
  • 52-Week Range: $25.09 - $53.91
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 86.38
  • P/E Growth: 6.39
  • Market Cap: $3.85B
  • Outstanding Shares: 73,007,000
  • Beta: 0.4
Profitability:
  • Net Margins: -8.78%
  • Return on Equity: -10.20%
  • Return on Assets: -4.61%
Debt:
  • Debt-to-Equity Ratio: 0.76%
  • Current Ratio: 3.79%
  • Quick Ratio: 2.74%
Additional Links:
Companies Related to Cepheid:

Analyst Ratings

Consensus Ratings for Cepheid (NASDAQ:CPHD) (?)
Ratings Breakdown: 16 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.24)
Consensus Price Target: $41.87 (20.54% downside)

Analysts' Ratings History for Cepheid (NASDAQ:CPHD)
Show:
DateFirmActionRatingPrice TargetDetails
9/12/2016Robert W. BairdDowngradeOutperform -> Neutral$53.00View Rating Details
9/8/2016Citigroup Inc.DowngradeBuy -> Neutral$44.00 -> $53.00View Rating Details
9/7/2016Barclays PLCBoost Price TargetEqual Weight$36.00 -> $52.00View Rating Details
9/7/2016BTIG ResearchDowngradeBuy -> NeutralView Rating Details
9/7/2016Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details
9/6/2016Craig HallumDowngradeBuy -> HoldView Rating Details
9/6/2016Piper Jaffray Cos.DowngradeOverweight -> NeutralView Rating Details
9/6/2016Needham & Company LLCDowngradeBuy -> HoldView Rating Details
8/17/2016Jefferies GroupBoost Price TargetHold$28.00 -> $34.00View Rating Details
7/29/2016JPMorgan Chase & Co.Boost Price TargetNeutral$32.00 -> $35.00View Rating Details
6/29/2016Canaccord GenuityReiterated RatingHold$32.00View Rating Details
6/15/2016Morgan StanleyInitiated CoverageEqual Weight$30.00View Rating Details
4/1/2016Atlantic SecuritiesUpgradeNeutral -> OverweightView Rating Details
3/28/2016WedbushLower Price TargetOutperform$58.00 -> $55.00View Rating Details
2/3/2016Stifel NicolausLower Price TargetBuy$42.00 -> $38.00View Rating Details
2/3/2016Leerink SwannReiterated RatingMarket Perform$39.00 -> $33.00View Rating Details
1/6/2016Avondale PartnersInitiated CoverageOutperform$46.00View Rating Details
12/2/2015Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details
10/21/2015Evercore ISIUpgradeSell -> Hold$44.50 -> $32.50View Rating Details
10/21/2015MizuhoLower Price TargetBuy$60.00 -> $42.00View Rating Details
10/14/2015Goldman Sachs Group Inc.Lower Price Target$53.00 -> $30.00View Rating Details
10/14/2015Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
7/26/2015MKM PartnersReiterated RatingBuy$65.00 -> $72.00View Rating Details
7/24/2015Evercore Partners Inc.Reiterated RatingHold -> SellView Rating Details
4/26/2015Cantor FitzgeraldReiterated RatingBuy$62.00View Rating Details
4/24/2015JMP SecuritiesBoost Price TargetMarket Outperform$58.00 -> $67.00View Rating Details
1/30/2015Oppenheimer Holdings Inc.Boost Price TargetOutperform$57.00 -> $60.00View Rating Details
12/30/2014William BlairReiterated RatingBuyView Rating Details
12/30/2014Bank of America Corp.UpgradeNeutral -> BuyView Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Cepheid (NASDAQ:CPHD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/12/2016        
7/28/2016Q216($0.14)$0.05$145.82 million$146.00 millionViewListenView Earnings Details
4/28/2016Q116$0.01$0.08$140.35 million$144.80 millionViewN/AView Earnings Details
2/2/2016Q415($0.20)$0.07$146.95 million$147.00 millionViewN/AView Earnings Details
10/20/2015Q3($0.31)($0.13)$126.81 million$126.50 millionViewListenView Earnings Details
7/23/2015Q215($0.21)($0.06)$130.70 million$132.50 millionViewListenView Earnings Details
4/23/2015Q115($0.16)$0.01$125.50 million$132.60 millionViewN/AView Earnings Details
1/29/2015Q414($0.13)$0.11$125.34 million$131.50 millionViewN/AView Earnings Details
10/16/2014Q314($0.16)$0.06$110.10 million$115.20 millionViewListenView Earnings Details
7/17/2014Q214($0.13)$0.03$115.47 million$116.50 millionViewN/AView Earnings Details
4/17/2014Q114($0.17)($0.01)$104.90 million$106.90 millionViewN/AView Earnings Details
1/31/2014Q413($0.11)($0.15)$102.17 million$113.30 millionViewN/AView Earnings Details
10/17/2013Q313($0.11)($0.20)$93.70 million$100.10 millionViewN/AView Earnings Details
7/18/2013Q2 2013$0.04$0.02$92.57 million$96.00 millionViewN/AView Earnings Details
4/18/2013Q1 2013$0.10$0.11$89.12 million$91.90 millionViewN/AView Earnings Details
1/24/2013Q4 2012$0.11$0.20$92.87 million$92.40 millionViewN/AView Earnings Details
10/18/2012($0.07)($0.32)ViewN/AView Earnings Details
7/19/2012$0.11$0.11ViewN/AView Earnings Details
4/19/2012($0.01)($0.08)ViewN/AView Earnings Details
1/26/2012($0.02)($0.03)ViewN/AView Earnings Details
10/20/2011$0.02$0.03ViewN/AView Earnings Details
7/21/2011($0.01)$0.03ViewN/AView Earnings Details
4/20/2011($0.01)$0.01ViewN/AView Earnings Details
1/27/2011($0.02)$0.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cepheid (NASDAQ:CPHD)
Current Year EPS Consensus Estimate: $-0.23 EPS
Next Year EPS Consensus Estimate: $0.61 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.26)($0.16)($0.21)
Q2 20163($0.20)($0.17)($0.18)
Q3 20163($0.18)($0.11)($0.15)
Q4 20162($0.03)($0.01)($0.02)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cepheid (NASDAQ:CPHD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cepheid (NASDAQ:CPHD)
Insider Ownership Percentage: 4.16%
Institutional Ownership Percentage: 95.32%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/17/2016Scott A CampbellVPSell287$36.16$10,377.92View SEC Filing  
8/4/2016Scott A CampbellVPSell746$36.71$27,385.66View SEC Filing  
5/3/2016Scott A CampbellVPSell2,058$27.90$57,418.20View SEC Filing  
5/2/2016Peter V FarrellEVPSell390$28.90$11,271.00View SEC Filing  
4/28/2016Peter V FarrellEVPSell390$36.30$14,157.00View SEC Filing  
4/25/2016John L BishopCEOSell110,000$35.50$3,905,000.00View SEC Filing  
3/10/2016Peter V FarrellEVPSell393$33.01$12,972.93View SEC Filing  
2/8/2016Warren C. Kocmond, Jr.COOSell292$28.53$8,330.76View SEC Filing  
2/1/2016Warren C. Kocmond, Jr.COOSell351$28.44$9,982.44View SEC Filing  
1/22/2016Warren C. Kocmond, Jr.COOSell157$33.16$5,206.12View SEC Filing  
12/10/2015Peter V. FarrellEVPSell394$31.67$12,477.98View SEC Filing  
11/20/2015Robert J EastonDirectorSell3,206$36.02$115,480.12View SEC Filing  
11/17/2015Robert J EastonDirectorSell2,724$34.84$94,904.16View SEC Filing  
11/12/2015Robert J EastonDirectorSell2,556$35.01$89,485.56View SEC Filing  
10/30/2015Peter V. FarrellEVPSell1,560$33.89$52,868.40View SEC Filing  
8/27/2015Peter V. FarrellEVPSell1,577$48.67$76,752.59View SEC Filing  
8/25/2015Cristina KepnerDirectorBuy10,000$47.78$477,800.00View SEC Filing  
6/26/2015Warren C Kocmond JrCOOSell9,375$61.52$576,750.00View SEC Filing  
4/29/2015Thomas L GutshallDirectorSell1,800$56.62$101,916.00View SEC Filing  
4/21/2015Joseph H SmithEVPSell91,866$54.51$5,007,615.66View SEC Filing  
4/20/2015John L BishopCEOSell100,000$55.20$5,520,000.00View SEC Filing  
2/25/2015Hollings RentonDirectorSell9,375$57.76$541,500.00View SEC Filing  
2/13/2015Dean O MortonDirectorSell12,500$58.51$731,375.00View SEC Filing  
2/3/2015Thomas D BrownDirectorSell12,500$56.29$703,625.00View SEC Filing  
1/30/2015Andrew MillerCFOSell6,677$57.64$384,862.28View SEC Filing  
1/12/2015Andrew MillerCFOSell11,719$56.65$663,881.35View SEC Filing  
1/12/2015David H PersingEVPSell5,000$56.90$284,500.00View SEC Filing  
1/12/2015Warren C Kocmond JrCOOSell4,688$57.00$267,216.00View SEC Filing  
1/5/2015Andrew MillerCFOSell2,250$54.95$123,637.50View SEC Filing  
1/5/2015Kerry FlomEVPSell8,694$54.21$471,301.74View SEC Filing  
11/19/2014Dean O MortonDirectorSell11,849$52.96$627,523.04View SEC Filing  
11/7/2014Hollings RentonDirectorSell9,375$51.07$478,781.25View SEC Filing  
10/31/2014Andrew MillerCFOSell12,167$53.84$655,071.28View SEC Filing  
10/31/2014David H PersingEVPSell20,000$53.34$1,066,800.00View SEC Filing  
10/31/2014Dean O MortonDirectorSell7,500$52.64$394,800.00View SEC Filing  
10/29/2014Kerry FlomEVPSell7,077$51.36$363,474.72View SEC Filing  
10/29/2014Thomas L GutshallDirectorSell12,500$51.63$645,375.00View SEC Filing  
10/28/2014David H PersingEVPSell15,000$51.51$772,650.00View SEC Filing  
10/3/2014Kerry FlomEVPSell1,271$44.52$56,584.92View SEC Filing  
8/7/2014Warren C Kocmond JrEVPSell324$38.69$12,535.56View SEC Filing  
7/14/2014Kerry FlomEVPSell2,812$49.72$139,812.64View SEC Filing  
7/3/2014Kerry FlomEVPSell1,282$48.97$62,779.54View SEC Filing  
5/29/2014Kerry FlomEVPSell4,265$45.49$194,014.85View SEC Filing  
5/22/2014Warren C Kocmond JrEVPSell1,300$42.38$55,094.00View SEC Filing  
4/29/2014Kerry FlomEVPSell2,660$42.38$112,730.80View SEC Filing  
4/25/2014John BishopCEOSell107,651$43.93$4,729,108.43View SEC Filing  
4/22/2014John BishopCEOSell42,349$46.11$1,952,712.39View SEC Filing  
4/22/2014Robert EastonDirectorSell12,500$45.59$569,875.00View SEC Filing  
4/3/2014Kerry FlomEVPSell1,621$51.55$83,562.55View SEC Filing  
4/1/2014Andrew MillerCFOSell4,688$52.78$247,432.64View SEC Filing  
3/13/2014Andrew MillerCFOSell17,265$55.55$959,070.75View SEC Filing  
1/31/2014Andrew MillerCFOSell63,375$53.10$3,365,212.50View SEC Filing  
1/31/2014John BishopCEOSell150,000$50.67$7,600,500.00View SEC Filing  
1/31/2014Joseph SmithEVPSell50,000$51.15$2,557,500.00View SEC Filing  
1/3/2014Kerry FlomEVPSell6,357$45.66$290,260.62View SEC Filing  
1/2/2014Andrew MillerCFOSell2,437$45.92$111,907.04View SEC Filing  
12/23/2013Kerry FlomEVPSell10,000$46.51$465,100.00View SEC Filing  
10/30/2013David H PersingVPSell5,000$41.35$206,750.00View SEC Filing  
10/29/2013Kerry FlomEVPSell2,660$40.50$107,730.00View SEC Filing  
10/24/2013Thomas L GutshallDirectorSell3,000$40.07$120,210.00View SEC Filing  
10/18/2013David H PersingVPSell20,000$40.59$811,800.00View SEC Filing  
9/24/2013Thomas GutshallDirectorSell3,000$38.97$116,910.00View SEC Filing  
9/18/2013David PersingVPSell5,000$39.34$196,700.00View SEC Filing  
9/16/2013David PersingVPSell5,000$38.95$194,750.00View SEC Filing  
9/6/2013David H PersingVPSell20,000$37.99$759,800.00View SEC Filing  
8/30/2013David PersingVPSell5,129$36.62$187,823.98View SEC Filing  
8/26/2013Thomas GutshallDirectorSell3,000$36.38$109,140.00View SEC Filing  
8/21/2013Robert EastonDirectorSell7,500$35.01$262,575.00View SEC Filing  
7/24/2013Thomas L GutshallDirectorSell3,000$34.18$102,540.00View SEC Filing  
6/24/2013Thomas L GutshallDirectorSell3,000$32.91$98,730.00View SEC Filing  
5/28/2013Andrew MillerCFOSell22,468$38.51$865,242.68View SEC Filing  
5/24/2013Thomas L GutshallDirectorSell3,000$37.90$113,700.00View SEC Filing  
5/13/2013Kerry FlomEVPSell6,832$39.76$271,640.32View SEC Filing  
3/25/2013Thomas L GutshallDirectorSell3,000$38.28$114,840.00View SEC Filing  
2/4/2013Joseph H SmithEVPSell38,400$36.20$1,390,080.00View SEC Filing  
12/24/2012Thomas L GutshallDirectorSell3,000$33.06$99,180.00View SEC Filing  
11/26/2012Thomas L GutshallDirectorSell7,778$31.94$248,429.32View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cepheid (NASDAQ:CPHD)
DateHeadline
News IconFeatured Stock: Parsley Energy, Inc. (NYSE:PE), CEPHEID (NASDAQ:CPHD) - Newburgh Press (NASDAQ:CPHD)
newburghpress.com - September 27 at 4:23 PM
stocksdaily.net logoCEPHEID (NASDAQ:CPHD) EPS Projection For FY2016 At $0.17 (NASDAQ:CPHD)
www.stocksdaily.net - September 27 at 8:58 AM
News IconOverbuying Stock Buzz: Cepheid (NASDAQ:CPHD) - Post Registrar (NASDAQ:CPHD)
postregistrar.com - September 26 at 4:35 PM
feeds.benzinga.com logoProxy Statement Shows Danaher Faced Competition In Bid To Buy Cepheid (NASDAQ:CPHD)
feeds.benzinga.com - September 26 at 2:25 PM
seekingalpha.com logoDanaher: A Solid Blue Chip Stock For Value Investors (NASDAQ:CPHD)
seekingalpha.com - September 26 at 9:04 AM
News IconCepheid (NASDAQ:CPHD) Earnings Preview: Should Investors Be ... - The Voice Registrar (NASDAQ:CPHD)
voiceregistrar.com - September 23 at 9:29 AM
News IconCepheid (CPHD) Updates FY15 Earnings Guidance - Petro Global News 24 (NASDAQ:CPHD)
petroglobalnews24.com - September 23 at 9:29 AM
News IconCepheid's (CPHD): Volatile Movement - Hot Stocks Point (NASDAQ:CPHD)
www.hotstockspoint.com - September 23 at 9:29 AM
mysmartrend.com logoCepheid Shares Up 76.4% Since SmarTrend's Buy Recommendation (CPHD) (NASDAQ:CPHD)
www.mysmartrend.com - September 22 at 4:29 PM
News IconInvestor News: Buyout of Cepheid (NASDAQ:CPHD) faces Investigation (NASDAQ:CPHD)
www.groundreport.com - September 22 at 9:57 AM
News IconCepheid (CPHD) Downgraded by Cowen and Company to "Market Perform" (NASDAQ:CPHD)
myhealthbowl.com - September 19 at 5:11 PM
News IconTech Stocks Alerts= Cepheid (NASDAQ:CPHD), Telefonaktiebolaget ... - share market updates (press release) (NASDAQ:CPHD)
sharemarketupdates.com - September 15 at 4:47 PM
streetinsider.com logoCepheid (CPHD) Announces Expanded CDT Gene Presence with Leading C. Difficile Test - StreetInsider.com (NASDAQ:CPHD)
www.streetinsider.com - September 15 at 4:47 PM
publicnow.com logoCepheid Announces Expansion Of The Most Comprehensive Molecular C. Difficile Product Portfolio On The Market (NASDAQ:CPHD)
www.publicnow.com - September 15 at 4:47 PM
mysmartrend.com logoCepheid Has Returned 76.1% Since SmarTrend Recommendation (CPHD) (NASDAQ:CPHD)
www.mysmartrend.com - September 15 at 10:08 AM
finance.yahoo.com logoCepheid's (CPHD) Shares March Higher, Can It Continue? (NASDAQ:CPHD)
finance.yahoo.com - September 14 at 4:25 PM
News IconTwo Technology Stocks Are Hot: Cepheid (CPHD), Rackspace ... - National Daily Press (NASDAQ:CPHD)
www.nationaldailypress.com - September 14 at 8:42 AM
thestreet.com logoCepheid (CPHD) Stock Downgraded to 'Neutral' at Baird - TheStreet.com (NASDAQ:CPHD)
www.thestreet.com - September 14 at 8:42 AM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Shareholders To Contact The Firm For Additional Information (NASDAQ:CPHD)
finance.yahoo.com - September 13 at 9:12 AM
thestreet.com logoCepheid (CPHD) Stock Downgraded to 'Neutral' at Baird (NASDAQ:CPHD)
www.thestreet.com - September 12 at 4:11 PM
istreetwire.com logo3 Trending Stocks: Cepheid (CPHD), Novavax, Inc. (NVAX), LendingClub Corporation (LC) - iStreetWire (NASDAQ:CPHD)
istreetwire.com - September 10 at 8:58 AM
News IconAnalysts Valuations For Two Stocks: Cepheid (NASDAQ:CPHD ... - The Voice Registrar (NASDAQ:CPHD)
voiceregistrar.com - September 10 at 8:58 AM
prnewswire.com logoCEPHEID SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Cepheid (CPHD) Over the ... - PR Newswire (press release) (NASDAQ:CPHD)
www.prnewswire.com - September 10 at 8:58 AM
prnewswire.com logoCepheid Acquisition May Not Be in the Best Interests of CPHD ... - PR Newswire (press release) (NASDAQ:CPHD)
www.prnewswire.com - September 10 at 8:58 AM
finance.yahoo.com logoCEPHEID SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Cepheid (CPHD) Over the Proposed Sale of the Company to Danaher Corporation (NASDAQ:CPHD)
finance.yahoo.com - September 10 at 8:58 AM
finance.yahoo.com logoCepheid Acquisition May Not Be in the Best Interests of CPHD Shareholders (NASDAQ:CPHD)
finance.yahoo.com - September 9 at 4:13 PM
finance.yahoo.com logoSHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Cepheid -CPHD (NASDAQ:CPHD)
finance.yahoo.com - September 9 at 9:08 AM
thestreet.com logoCepheid (CPHD) Stock Price Target Raised at Barclays on Danaher Deal - TheStreet.com (NASDAQ:CPHD)
www.thestreet.com - September 8 at 4:13 PM
finance.yahoo.com logoCepheid downgraded by Citigroup (NASDAQ:CPHD)
finance.yahoo.com - September 8 at 4:13 PM
finance.yahoo.com logoWill Cepheid's (CPHD) Buyout by Danaher be a Strategic Fit? (NASDAQ:CPHD)
finance.yahoo.com - September 8 at 4:13 PM
capitalcube.com logoCepheid – Value Analysis (NASDAQ:CPHD) : September 8, 2016 (NASDAQ:CPHD)
www.capitalcube.com - September 8 at 4:13 PM
finance.yahoo.com logoCepheid Targets Development of a Point of Care HIV Viral Load Test From a Few Drops of Blood (NASDAQ:CPHD)
finance.yahoo.com - September 8 at 4:13 PM
fidaily.com logoCEPHEID (CPHD) - Citigroup Downgrades Rating Lowers Price Target - Finance Daily (NASDAQ:CPHD)
www.fidaily.com - September 8 at 8:08 AM
News IconNews Recap: Carnival Corp (NYSE:CCL), Cepheid (NASDAQ:CPHD), Hess Corp. (NYSE:HES) - NYSE Journal (press release) (NASDAQ:CPHD)
stockznews.com - September 8 at 8:08 AM
News IconMost Active Mix Cap Movers- Cepheid (NASDAQ:CPHD), HCA Holdings (NYSE:HCA), Antero Midstream Partners ... - Seneca Globe (NASDAQ:CPHD)
www.senecaglobe.com - September 8 at 8:08 AM
News IconCepheid (CPHD) Stock Exploding On DHR Acquisition (NASDAQ:CPHD)
cnafinance.com - September 7 at 4:28 PM
News IconCepheid (CPHD) Stock Rating Lowered by Needham & Company LLC (NASDAQ:CPHD)
christiannewstoday.com - September 7 at 4:28 PM
rttnews.com logoCepheid (CPHD) Leaped To An 11-Month High After Acquired By Danaher (NASDAQ:CPHD)
www.rttnews.com - September 7 at 4:28 PM
finance.yahoo.com logoCepheid (CPHD) Gets FDA Clearance for Xpert TV Assay (NASDAQ:CPHD)
finance.yahoo.com - September 7 at 4:28 PM
thestreet.com logoCepheid (CPHD) Stock Price Target Raised at Barclays on Danaher Deal (NASDAQ:CPHD)
www.thestreet.com - September 7 at 4:28 PM
marketrealist.com logoWhat Made Cepheid Attractive to Danaher? (NASDAQ:CPHD)
marketrealist.com - September 7 at 4:28 PM
marketrealist.com logoDHR to Reap $200 Million in Cost Synergies, Revenue through Buy (NASDAQ:CPHD)
marketrealist.com - September 7 at 4:28 PM
feeds.benzinga.com logoBTIG Sees Another Bidder For Cepheid 'Unlikely' (NASDAQ:CPHD)
feeds.benzinga.com - September 7 at 12:26 PM
fidaily.com logoNeedham Downgrades Rating On CEPHEID (CPHD) To “Hold” - Finance Daily (NASDAQ:CPHD)
www.fidaily.com - September 6 at 9:20 PM
feeds.benzinga.com logoBenzinga's M&A Chatter for Tuesday September 6, 2016 (NASDAQ:CPHD)
feeds.benzinga.com - September 6 at 8:21 PM
investorplace.com logoWhy Cepheid (CPHD), Spectra Energy Corp. (SE) and Navistar International Corp (NAV) Are 3 of Today’s Best Stocks (NASDAQ:CPHD)
investorplace.com - September 6 at 5:00 PM
investorplace.com logoWhy Cepheid (CPHD), Spectra Energy Corp. (SE) and Navistar International Corp (NAV) Are 3 of Today’s Best Stocks (NASDAQ:CPHD)
investorplace.com - September 6 at 4:54 PM
benzinga.com logoCoLucid Pharmaceuticals (NYSE:CLCD), CEPHEID (NASDAQ ... - Benzinga (NASDAQ:CPHD)
www.benzinga.com - September 6 at 4:16 PM
fidaily.com logoNeedham Cuts Rating On CEPHEID (CPHD) To "Hold" - Finance Daily (NASDAQ:CPHD)
www.fidaily.com - September 6 at 4:16 PM
News IconCepheid (NASDAQ:CPHD) Earnings Preview: Should Investors Be Nervous? - The Voice Registrar (NASDAQ:CPHD)
voiceregistrar.com - September 6 at 4:16 PM

Social

Cepheid (NASDAQ:CPHD) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff